International Journal of Radiation Oncology, Biology, Physics 1996: Vol 36 Index

9 Pages·1996·1.9 MB·English

AUTHOR INDEX
Volume 36, 1996
Abe, M., 1169, 1263 Bostwick, D.G., 585 Dajani, L., 83 Finger, P.T., 861
Abel, U., 1085 Bosworth, J.L., 861 Dale, R.G., 739 Finlay, J., 29
Acker, J.C., 593 Boterberg, T., 1233 Daly-Schveitzer, N., 999 Flamant, F., 533
Adams, J.A., 721 Béttcher, H.D., 835 Da Motta, N.W., 49 Flickinger, J.C., 275, 873, 1045
Akhileswaran, R., 1039 Brabbins, D.S., 565 Danova, M., 1137 Foppiano, F., 1147
Albano, K., 699 Bradford, C.R., 469 DaRosso, R., 1155 Forman, J.D., 673
Alekhteyar, K.M., 321 Brady, L.W., 857, 963 David, J.-M., 999 Fornander, T., 899
Alexander, E., Il, 141 Branch, C., 641 Davis, C.S., 623 Fourquet, A., 615
Alfieri, A.A., 861 Brennan, M.F., 321 Deasy, J.0., 933 Fowble, B.L., 731
Ali, M.N., 777 Brenner, D.J., 805 Deen, D.F., 95 Freire, J., 857
Allen, J.C., 1155 Bridgman, S.M., 49 DeFelice, C.A., 777 French, B.A., 777
Allen, P., 607 Broét, P., 615 de la Rochefordiére, A., 615 Friedrichsen, E.J., 867
Allen, P.K., 601 Brosteanu, O., 305 Delrowe, J., 37 Friehs, G.M., 1045
Almond, P.R., 933 Brown, G., 857 DelRowe, J.D., 673, 1163 Fritz, P., 147
Alzieu, C., 999 Brown, K.C., 573 Demas, W., 37 Fuchihata, H., 1201
Amols, H., 767 Biichner, C., 1055 Demers, G.W., 1099 Fuchs, M., 1085
Amols, H.1., 689, 913 Buller, R.E., 623 Denekamp, J., 497 Fujii, T., 601
Ang, K.K., 1005 Burger, P.C., 557 De Neve, W., 1233 Fujishiro, S., 1169
Antognoni, P., 1137 Burk, M., 345 Deshmukh, A., 83 Fulton, D.S., 1163
Antonuk, L.E., 661 Butler, E.B., 777 Dewey, W.C., 95 Furukawa, S., 1201
Archambeau, J.O., 867 Buzydlowski, J.W., 673 Dewhirst, M.W., 1177
Ash, R.C., 67 Dewit, L., 267 Gaber, M.H., 1177
Asselain, B., 615 Campana, F., 615 Diehl, V., 305 Gajdusek, C.M., 821
Atkinson, C.H., 481 Caplan, R., 37 Dinapoli, R., 1045 Gall, K., 443
Au, D.K.K., 281 Cardiges, N.M., 49 Dinshaw, K.A., 941 Galloway, D.A., 1099
Augsburger, J., 857 Carlens, P., 899 Dmuchowski, C.F., 565 Garden, A.S., 1005
Austin-Seymour, M., 87 Carli, M., 533 Donahue, B., 1155 Gaspar, L., 549
Austin-Seymour, M.M., 451 Carter, A.J., 797 Donaldson, S.S., 533, 747, 969 Gaynon, P., 19
Ayyangar, K.M., 205 Cazzaniga, L.F., 1137 Douglas, J.G., 87 Geara, F., 1005
Chambers, J., 829 Douglas, R.M., 443 Gebarski, S.S., 469
Bachaud, J.-M., 999, 1013, 1285 Chang, J.T., 1019 Dresler, C.M., 1215 Gefeller, D., 1077
Bakker, P.J.M., 135 Chang, S.M., 433 Dunkel, I.J., 29 Gehan, E., 533
Balter, J.M., 167 Chao, K.S.C., 1039 Dunphy, E., 355 Georgii, A., 305
Barbera, F., 1137 Chaplain, G., 1013 Dusenbery, K.E., 335 Gillin, M., 699
Bardelli, D., 1137 Chen, A.S.J., 1225 Diihmke, E., 305 Giordano, M., 1137
Barendsen, G.W., 197 Chen, G., 541, 1251 Giraud, P., 1285
Bartelink, H., 267 Chen, K.Y., 1127 Earle, J.D., 585 Glas, U., 899
Bauersachs, R., 835 Chen, P.Y., 565 Ebe, K., 1107 Glickson, J.D., 635
Bauman, G.S., 433 Cherlow, J.M., 19 Eenmaa, J., 189 Glisson, B.S., 1005
Beatty, J., 443 Cho, P., 87 Ege, G.N., 487 Gobbel, G.T., 113
Becker, K., 305 Chobe, R.J., 83 Eggleston, W.D., 345 Goitein, M., 519
Belkacémi, Y., 77 Choi, P., 291 Ehrhardt, J.C., 623 Gonzalez, J., 565
Bellinzona, M., 113 Choy, D.T.K., 281 Eisbruch, A., 469 Gore, E.M., 67
Benk, V., 533 Chua, D.T.T., 281 El-Mohni, Y., 661 Gorin, N.-C., 77
Bentzen, S.M., 247 Chung, S.S., 1045 Emami, B., 1039, 1215 Goswitz, M.S., 311
Berberich, W., 1085 Clark, D., 881 Emery, R., 861 Graham, M.M., 417
Berns, C., 147 Coffey, R.J., 1045 Engel, R.E., 345 Graham, M.V., 1215
Berson, A.M., 861 Cohen-Jonathan, E., 999 Ennis, R., 913 Grau, C., 515
Bhujwalla, Z.M., 635 Coia, L.R., 13 Ennis, R.D., 767 Greenwald, C., 541
Bianco, J.A., 1099 Coleman, C.N., 673 Erickson, B., 699 Gregoritch, S.J., 981
Biggs, P., 443 Coleman, M., 429 Eschwége, F., 1013 Greig, J.R., 463
Bignardi, M., 1137 Constine, L.S., 253, 881 Esclamado, R.M., 469 Griffin, R.J., 377
Blacharski, P.A., 867 Cooper, J.D., 1215 Evans, M.L., 417 Griffin, T.W., 87, 829
Black, P.M., 141 Corn, B.W., 13, 965 Ezov, N., 649 Groudine, M., 1099
Blackstock, A.W., 641 Corvo, R., 1147 Guarneri, E.M., 973
Blazar, B.R., 335 Coughlin, C., 37 Fabrini, M.G., 549 Guseva, L.I., 685
Bleyer, W.A., 19 Crocker, LR., 959 Fajardo, L.F., 777, 971 Gutin, P.H., 433, 1045
Blute, M.L. Curran, W.J., 965 Falk, P.M., 61 Gyenes, G., 899
Bolek, T.W., 329 Curran, W.J., Jr., 13, 1279 Farnan, N., 1163
Boothman, D.A., 361, 369 Fein, D.A., 13 Haas, M., 95
Bosch, W.R., 159 Dabaghi, S.F., 777 Fike, J.R., 113 Haas-Kogan, D.A., 95
Bossi, A., 1137 Dahl, O., 403 Filice, S., 711 Haddock, M.G., 557
XVII
AUTHOR INDEX
Volume 36, 1996
Abe, M., 1169, 1263 Bostwick, D.G., 585 Dajani, L., 83 Finger, P.T., 861
Abel, U., 1085 Bosworth, J.L., 861 Dale, R.G., 739 Finlay, J., 29
Acker, J.C., 593 Boterberg, T., 1233 Daly-Schveitzer, N., 999 Flamant, F., 533
Adams, J.A., 721 Béttcher, H.D., 835 Da Motta, N.W., 49 Flickinger, J.C., 275, 873, 1045
Akhileswaran, R., 1039 Brabbins, D.S., 565 Danova, M., 1137 Foppiano, F., 1147
Albano, K., 699 Bradford, C.R., 469 DaRosso, R., 1155 Forman, J.D., 673
Alekhteyar, K.M., 321 Brady, L.W., 857, 963 David, J.-M., 999 Fornander, T., 899
Alexander, E., Il, 141 Branch, C., 641 Davis, C.S., 623 Fourquet, A., 615
Alfieri, A.A., 861 Brennan, M.F., 321 Deasy, J.0., 933 Fowble, B.L., 731
Ali, M.N., 777 Brenner, D.J., 805 Deen, D.F., 95 Freire, J., 857
Allen, J.C., 1155 Bridgman, S.M., 49 DeFelice, C.A., 777 French, B.A., 777
Allen, P., 607 Broét, P., 615 de la Rochefordiére, A., 615 Friedrichsen, E.J., 867
Allen, P.K., 601 Brosteanu, O., 305 Delrowe, J., 37 Friehs, G.M., 1045
Almond, P.R., 933 Brown, G., 857 DelRowe, J.D., 673, 1163 Fritz, P., 147
Alzieu, C., 999 Brown, K.C., 573 Demas, W., 37 Fuchihata, H., 1201
Amols, H., 767 Biichner, C., 1055 Demers, G.W., 1099 Fuchs, M., 1085
Amols, H.1., 689, 913 Buller, R.E., 623 Denekamp, J., 497 Fujii, T., 601
Ang, K.K., 1005 Burger, P.C., 557 De Neve, W., 1233 Fujishiro, S., 1169
Antognoni, P., 1137 Burk, M., 345 Deshmukh, A., 83 Fulton, D.S., 1163
Antonuk, L.E., 661 Butler, E.B., 777 Dewey, W.C., 95 Furukawa, S., 1201
Archambeau, J.O., 867 Buzydlowski, J.W., 673 Dewhirst, M.W., 1177
Ash, R.C., 67 Dewit, L., 267 Gaber, M.H., 1177
Asselain, B., 615 Campana, F., 615 Diehl, V., 305 Gajdusek, C.M., 821
Atkinson, C.H., 481 Caplan, R., 37 Dinapoli, R., 1045 Gall, K., 443
Au, D.K.K., 281 Cardiges, N.M., 49 Dinshaw, K.A., 941 Galloway, D.A., 1099
Augsburger, J., 857 Carlens, P., 899 Dmuchowski, C.F., 565 Garden, A.S., 1005
Austin-Seymour, M., 87 Carli, M., 533 Donahue, B., 1155 Gaspar, L., 549
Austin-Seymour, M.M., 451 Carter, A.J., 797 Donaldson, S.S., 533, 747, 969 Gaynon, P., 19
Ayyangar, K.M., 205 Cazzaniga, L.F., 1137 Douglas, J.G., 87 Geara, F., 1005
Chambers, J., 829 Douglas, R.M., 443 Gebarski, S.S., 469
Bachaud, J.-M., 999, 1013, 1285 Chang, J.T., 1019 Dresler, C.M., 1215 Gefeller, D., 1077
Bakker, P.J.M., 135 Chang, S.M., 433 Dunkel, I.J., 29 Gehan, E., 533
Balter, J.M., 167 Chao, K.S.C., 1039 Dunphy, E., 355 Georgii, A., 305
Barbera, F., 1137 Chaplain, G., 1013 Dusenbery, K.E., 335 Gillin, M., 699
Bardelli, D., 1137 Chen, A.S.J., 1225 Diihmke, E., 305 Giordano, M., 1137
Barendsen, G.W., 197 Chen, G., 541, 1251 Giraud, P., 1285
Bartelink, H., 267 Chen, K.Y., 1127 Earle, J.D., 585 Glas, U., 899
Bauersachs, R., 835 Chen, P.Y., 565 Ebe, K., 1107 Glickson, J.D., 635
Bauman, G.S., 433 Cherlow, J.M., 19 Eenmaa, J., 189 Glisson, B.S., 1005
Beatty, J., 443 Cho, P., 87 Ege, G.N., 487 Gobbel, G.T., 113
Becker, K., 305 Chobe, R.J., 83 Eggleston, W.D., 345 Goitein, M., 519
Belkacémi, Y., 77 Choi, P., 291 Ehrhardt, J.C., 623 Gonzalez, J., 565
Bellinzona, M., 113 Choy, D.T.K., 281 Eisbruch, A., 469 Gore, E.M., 67
Benk, V., 533 Chua, D.T.T., 281 El-Mohni, Y., 661 Gorin, N.-C., 77
Bentzen, S.M., 247 Chung, S.S., 1045 Emami, B., 1039, 1215 Goswitz, M.S., 311
Berberich, W., 1085 Clark, D., 881 Emery, R., 861 Graham, M.M., 417
Berns, C., 147 Coffey, R.J., 1045 Engel, R.E., 345 Graham, M.V., 1215
Berson, A.M., 861 Cohen-Jonathan, E., 999 Ennis, R., 913 Grau, C., 515
Bhujwalla, Z.M., 635 Coia, L.R., 13 Ennis, R.D., 767 Greenwald, C., 541
Bianco, J.A., 1099 Coleman, C.N., 673 Erickson, B., 699 Gregoritch, S.J., 981
Biggs, P., 443 Coleman, M., 429 Eschwége, F., 1013 Greig, J.R., 463
Bignardi, M., 1137 Constine, L.S., 253, 881 Esclamado, R.M., 469 Griffin, R.J., 377
Blacharski, P.A., 867 Cooper, J.D., 1215 Evans, M.L., 417 Griffin, T.W., 87, 829
Black, P.M., 141 Corn, B.W., 13, 965 Ezov, N., 649 Groudine, M., 1099
Blackstock, A.W., 641 Corvo, R., 1147 Guarneri, E.M., 973
Blazar, B.R., 335 Coughlin, C., 37 Fabrini, M.G., 549 Guseva, L.I., 685
Bleyer, W.A., 19 Crocker, LR., 959 Fajardo, L.F., 777, 971 Gutin, P.H., 433, 1045
Blute, M.L. Curran, W.J., 965 Falk, P.M., 61 Gyenes, G., 899
Bolek, T.W., 329 Curran, W.J., Jr., 13, 1279 Farnan, N., 1163
Boothman, D.A., 361, 369 Fein, D.A., 13 Haas, M., 95
Bosch, W.R., 159 Dabaghi, S.F., 777 Fike, J.R., 113 Haas-Kogan, D.A., 95
Bossi, A., 1137 Dahl, O., 403 Filice, S., 711 Haddock, M.G., 557
XVII
Hahn, E.W., 385 Johnson, D., 83 Langston, J.W., 1251 Mayberg, M.R., 821, 829
Haida, T., 29 Johnson, E., 1117 Laporte, J.-P., 77 Mayr, N.A., 623
Hall, E.J., 805 Johnson, M., 1225 Laramore, G.E., 87, 241 Mazur, W., 777
Hall, W.A., 511 Johnson, P.J., 291 Larson, D.A., 433, 1045 McDermott, M., 1045
Hallahan, D.E., 355 Jones, B., 739 Laugier, A., 77 McDermott, M.W., 433
Halperin, E.C., 233 Jones, D., 541 Laurie, J.A., 345 McGlave, P.B
Hamers, H.P., 549 Lawrence, T.S., 167 McNeeley, S.W., 205
Hamilton, C.S., 181 Kagan, A.R., 61 Lawton, C.A., 67, 673 Mella, O., 393, 403
Hanks, G.E., 731 Kalet, [.J., 451 Le, T., 1099 Mellenberg, D.E., 623
Hanlon, A., 731 Kalnicki, S., 1225, 1283 Leber, K., 1045 Meltzer, A., 649
Hanlon, A.L., 13 Kamath, S.S., 325 Lee, S.P., 1019 Mendenhall, N.P., 329
Harms, W.B., 159 Kampinga, H.H., 125 Lee, W.Y., 291 Mendenhall, W.M., 351
Harrison, L., 681 Kanwar, Y.S., 907 Lehrke, R., 1055 Menten, J., 549
Harrison, L.B., 321 Karim, A.B.M.F., 549 Leibel, S.A., 29 Merchant, T.E., 29
Hartford, A.C., 721 Kaufmann, T., 429 Leon, M.B., 973 Micaily, B., 857
Hartmann, G.H., 385 Keilholz, L., 891 Leopold, K.A., 593 Michalowski, A.S., 1285
Haselsberger, K., 1045 Kersey, J.H., 335 Lesnicar, H., 1025 Michalski, J., 573
Hasenclever, D., 305 Khan, M.M., 777 Lester, S.G., 1163 Mijnheer, B., 267
Hassenstein, E.O.M., 1077 King, S.B., 789 Leung, D.H., 321 Milas, L., 601
Hatlevoll, R., 549 King, S.C., 593 Leung, S.F., 291 Miller, R., 83
Hayter, C.R.R., 487 King, V., 881 Levi, D., 95 Miller, R.C., 805
Heideman, R.L., 1251 Kingsley, P.B., 1251 Lewellen, T.K., 417 Miller, R.W., 463
Henk, J.M., 213 Kinsella, T.J., 361, 369, 1163 Li, Y.P., 1169 Mintz, G.S., 973
Henke, K., 385 Kipp, J.B.A., 135 Lichter, A.S., 469 Mitsumori, M., 1169
Hensley, F.W., 147 Klein, E.E., 1189 Liermann, D., 835 Mittal, B.B., 907
Henzler, M., 881 Kliauga, P., 689 Lin, J.-C., 1127 Miyamoto, C.T., 857
Heyd, R., 835 Kocher, M., 1055 Lindsley, K.L., 29, 87, 829 Miyata, Y., 1107
Higashihara, T., 1221 Kogan, S.S., 95 Lionetto, R., 1147 Miyauchi, K., 1221
Hill, M., 345 Kogut, N., 61 Lipchik, R.J., 67 Mizowaki, T., 1091
Hiraoka, M., 1091, 1169 Koh, W.-J., 87, 417, 829 Lippman, S.M., 1005 Moni, J., 847
Hirato, M., 1045 Koishi, M., 1169 Litz, C., 335 Montgomery, C.T., 83
Ho, W.K., 281 Kollath, J., 835 Lockett, M.A., 573 Moore, G.J., 351
Hollander, J., 565 Komaki, R., 601, 607 Loeffler, J.S., 141 Moore, R.L., 345
Holmberg, E., 1065 Kondziolka, D., 275, 873, 1045 Loeffler, M., 305 Morgan, G.W., 219
Hong, J.-H., 1019 Konings, A.W.T., 125 London, S., 821 Morgan, T.L., 61
Hong, K., 1177 Konishi, J., 1091 Longton, W.A., 857 Moros, E.G., 1189
Hong, W.K., 1005 Kooy, H.M., 141 Loprinzi, C.L., 345 Morris, N.B., 973
Honma, Y., 1107 Kozuka, T., 1221 Loredo, L.N., 867 Morrison, W.H., 1005
Hoppe, R.T., 3 Kraft, A., 355 Low, D.A., 1189 Mortimer, J.E., 1215
Horiot, J.C., 549 Krikunova, L.I., 685 Lunsford, L.D., 275, 873, 1045 Mountain, C.F., 601
Horning, S.J., 3 Krohn, K.A., 417 Luse, R.W., 189 Mouret-Fourme, E., 615
Horwitz, E.M., 565 Kron, T., 181 Lustig, R., 1117 Moyers, M.F., 867
Hsu, C.-Y., 1127 Krossnes, B.K., 393, 403 Lyons, M.K., 557 Mueller, R.-P., 305
Hu, L., 95 Kubale, R., 1085 Muhs, A.G., 881
Huang, S.K., 1177 Kuchibhotla, J., 355 Maat, B., 549 Miiller, R.-P., 1055
Huang, W., 661 Kuchta, J., 1055 Magnotta, V.A., 623 Murayama, S., 1201
Hudgins, W.R., 1045 Kumar, M., 541 Makepeace, C.M., 377 Myerson, R.J., 1189
Hummel, S.M., 451 Kun, L.E., 257, 541, 1251 Malissard, L., 1013
Hur, W.-J., 377 Kupelian, P.A., 607 Mallett, R., 83 Nagata, Y., 1169
Hussey, D.H., 623 Kuramitsu, T., 1107 Manegold, K.-H., 835 Nakagawa, M., 113
Hutson, A., 881 Kurtz, J.M., 923 Marboe, C., 767 Nakanishi, T., 1107
Kuruvilla, A., 83 Marcial, V.A., 673 Nakano, Y., 1091
Imamura, M., 1091 Kuske, R.R., 345 Marcus, R.B., Jr., 325, 329 Nath, R., 977
Ing, J., 867 Kussin, P.S., 593 Marina, N., 541 Nearhood, K., 345
Inoue, H.K., 1045 Kutcher, G.J., 731 Marks, L.B., 557, 593 Neglia, J.P., 335
Inoue, T., 1201 Kwan, W.H., 291 Marsh, L.H., 469 Ng, C.E., 105
Israel, M.A., 95 Kwiatkowski, T., 189 Martel, M.K., 469 Nguyen, T.D., 1013
Kwock, L., 641 Martin, D.D., 623 Nieder, C., 1085
Jacky, J.P., 451 Kwong, D.L.W., 281 Martinez, A.A., 565 Niemierko, A., 519, 721
Jager, J.J., 549 Marume, T., 1169 Niewald, M., 1085
Jagetia, R., 907 Laird, J.R., 797 Mascarenhas, F., 549 Nimrod, A., 649
Jahanzeb, M., 1215 Lam, K.L., 167 Mason, K.A., 601 Nirenberg, A., 1155
Jan, J.-S., 1127 Lamborn, K., 1045 Massullo, V., 973 Nisce, L.Z., 429
Jani, S., 973 Lamborn, K.R., 113 Matsunaga, N., 1107 Nishimura, Y., 1091, 1169
Jardine, P.A., 175 Lamond, J.P., 361, 369 Matthaei, D., 305 Nishiyama, K., 1221
Jenkins, J.J., 1251 Landis, J.R., 923 Matthews, J.W., 159 Noordman, E., 549
Jin, H., 973 Lang, P., 1117 Maurer, H., 533 Nori, D., 847
XIX
Norman, M.G., 557 Raaphorst, G.P., 105 Schwartz, R.G., 881 Teichman, S., 867
Nouet, P., 923 Rahl, C.G., 835 Scott, C.B., 1279 Teirstein, P.S., 973
Novak, L., Raizner, A.E., 777 Scott, N.A., 789 Teissie, J., 1285
Nyman, J., Rambert, P., 1013 Scott, W., 83 Ten Haken, R.K., 167, 469
Rampello, G., 1137 See, L.-C., 1019 Teo, P., 291
Ramsay, N.K.C., 335 Seegenschmiedt, M.H., 891 Tepper, J.E., 641
Oberley, L.W., 62:
Rapoport, A.P., 253 Sehlen, S., 305 Terrell, J.E., 469
Ochs, J.J.,
Rasey, J., 821 Seilhan, T.M., 113 Teshima, T., 1201
Odén, A.,
Rasey, J.S., 417, 829 Sen, A., 205 Teule, G.J.J., 197
O'Fallon, J.R., 345
Reddick, W.E., 1251 Serrano, E., 999 Thames, H.D., 247
Ogg, R.J., 1251
Reijnart, I.W.C., 811 Sessions, D., 1039 Théobald, S., 1013
Ohye, C., 1045
Reinstein, L.E., 913 Shah, K.H., 61 Thienpont, M., 1233
Okagawa, K., 1221
Rhomberg, W., 1077 Sham, J.S.T., 281 Thomas, D.G.T., 549
Okunieff, P., 443, 463
Okuno, Y., 1169 Rice, G.C., 1099 Shanahan, T.G., 345 Tian, H., 821
Richetti, A., 1137 Shank, B., 261 Tkoez, H.-J., 1085
Order, S.E., 969, 1117, 1285
Ostwald, P.M., 181 Rietbroek, R.C., 135 Shaw, E.G., 1045 Tome, M., 61
Ovadia, H., 649 Rio, B., 77 Sherr, D.L., 861 Touboul, E., 77
Overgaard, J., 515 Ro, J.Y., 601 Shetty, R., 907 Tran, A., 829
Owen, J.B., 731 Roberts, K.B., 977 Shezen, E., 649 Tremblay, D., 711
Ozsahin, M., 77 Robertson, J.M., 167 Shibazaki, T., 1045 Treuer, H., 1055
Rodary, C., 533 Shimada, Y., 1091 Treuner, I., 533
Rols, M.-P., 1285 Shimizutani, K., 1201 Trigg, M., 19
Pams, X., 1013 Roos, J.C., 197 Ship, J.A., 469 Tripuraneni, P., 973
Papahadjopoulos, D., 1177 Rosenberger, F.U., 159 Shipley, W.U., 721 Tubergen, D., 19
Papirov, I., 923 Rosenblum, M.K., 29 Shrieve, D.C., 141 Tubiana, M., 263
Paradis, P., Jr., 777 Roth, S., 305 Siegal, T., 649 Tungsubutra, K., 1275
Pardo, F.S., 443 Rotman, M., 37, 673 Siegel, J.A., 1117 Turesson, I., 1065
Parikh, S., 847 Roura, M., 83 Siewerdsen, J.H., 661 Turrisi, A.T., Ul, 753
Park, C.I., 1271 Rouzaud, M., 923 Simpson, J., 1039 Tyssebotn, L., 393
Parsai, E.1., 205
Roy, J., 681, 711 Singer, J.W., 1099
Parsons, J.T 351
Rubin, P., 531, 763, 881 Slater, J.D., 867 Unda, R., 857
Parvinen, L.M., 549
Ruehl, U., 305 Slater, J.M., 867 Unger, J.M., 451
Paryani, S.B., 83
Russell, K.J., 1099 Slawson, R.G., 49 Unlap, T., 355
Paulino, A.C., 541 Russo, R.J., 973 Small, W., Jr., 907 Urban, P., 841, 923
Payne, D., 487
Rutishauser, W., 923 Smid, L., 1025 Urias, R.E., 345
Peer, J., 83
Rutqvist, L.E., 899 Smith, A.R., 731 Urie, M.M., 721
Pelsang, R.E., 623
Rutten, E.H.J.M., 549 Sneed, P.K., 433, 1045 Urtasun, R.C., 1163
Pendl, G., 1045
Soatti, C., 1137
Péne, F., 77
Song, C.W., 377
Perez, C.A., 573 Saenko, A.S., 685 Sorosky, J.1., 623 Valenzuela, R.F., 443
Perkins, P., 601 Sakaguchi, M., 1107 Spector, G., 1039 van Alphen, A.M., 549
Peschel, R.E., 749 Salazar, O.M., 49 Spence, A.M., 241 van Assen, A.J., 125
Peschke, P., 385 Sandler, H., 661 Sperduto, P.W., 511 van Bree, C., 135
Peters, L.J., 1005 Sanford, R.A., 1251 Staar, S., 1055 van Dieren, E.B., 197
Peterson, L.M., 417 Sanguineti, G., 1147 Stalpers, L.J.A., 433 van Doorn, T., 175
Pfeffer, M.R., 649 Sano, T., 1169 Steinbuch, M., 335 van Eijkeren, M., 1233
Phillips, T.L., 1281 Sather, H., 19 Steinherz, P., 19 van Glabbeke, M., 549
Pierart, M., 549 Sauer, R., 891 Steuterman, S., 973 van Lingen, A., 197
Pisansky, T.M., 585 Scarantino, C.W., 37 Stewart, J.R., 971 van Ravels, F.J.M., 811
Plaizier, M.A.B.D., 197 Scarborough, M.T., 325 Strassmann, G., 835 van Reijn, M., 549
Podgorodnichenko, V.K., 685 Schatz, R.A., 973 Straube, W.L., 1189 van Waarde, M.A.W.H., 125
PPPPPPPooooooolhlelppillln,oimao, twacc ,skA,k ,Jk,. . iLMC.J.,.JA.B,, .J.. ., ,E, Y. 3.1,8 39, 131 73513287 74 51,, 897233 SSSSSSSccccccchhhhhhhieieenoflliiaefldbtb,p,,,h e p alePuMS,lT.e.. .,BErC,. . ,.K,, ., S 1, .0 9B,58 1.51153W8720 3. 88 ,35 557 SSSSSSSttutttuuudurrmaaaroorar,momttn ,,,tb, meH ar.JFV.n,g..V, P,,., . J 91,.0 1,1JE7 00.9. S75G05. 5.78,, 5 586151 VVVVVVViaieieoctrrdgrialaiemlnionseeirt,,,,,ut olV,eVFJC. ..n..,,,,A ,J .. 8,1M94 0.5S115,. 5,1 5,46 75 191 420134 5
Pouliot, J., 711
Principato, R., 1117 Scholl, S.M., 615 Sullivan, K.J., 451
Probert, J.C., 481 Schomberg, P.J., 345, 557 Sutton, D., 83 Waksman, R., 763, 789, 959
Puestow, E., 83 Schopman, E.M., 135 Sutton, L., 77 Wallace, M., 731
Schopohl, B., 835 Wallner, K., 681
Pui, M.H., 1251
Schraube, P., 147 Wallner, P.E., 1117
Purcell, J., 83
Schulte-Huermann, D., 835 Takayama, N., 1169 Walter, K., 1085
Purdy, J.A., 159
Schumacher, D., 189 Tang, S.G., 1019 Wang, C.-C., 1019
Schwager, M., 923 Tarte, B.J., 175 Wang, M., 361, 369
Quint, R., 1013 Schwartz, A., 767 Taylor, J.S., 1251 Wang, M.-H., 29
Wannenmacher, M., 147 Wilimas, J., 541 Wu, N.Z., 1177 Yuen, P.W., 281
Wara, W.M., 433, 1045 Wilkins, D.E., 105 Wu, P.M., 281 Yuh, W.T.C., 623
Weeks, K.J., 593 Wilkowski, R., 305 Wuu, C.S., 689
Wei, W.L., 281 Willcut, V.M., 1189 Zagars, G.K., 311
Weichselbaum, R.R., 355 Williams, M.S., 345 Xu, Z., 933 Zaider, M., 689, 913
Weinberger, J., 767, 913 Williamson, J.F., 1239 Zakotnik, B., 1025
Weintraub, W.S., 949 Willich, N., 305 Yamashita, T., 1263 Zamulaeva, I.A., 685
Wells, J., Jr., 83 Wolf, G.T., 469 Yonemoto, L.T., 867 Zeiger, L.E., 1117
Wen, B.-C., 623 Wondergem, J., 811 Yorkston, J., 661 Zeman, E.M., 641
Wheeler, J.A., 623 Wong, W.W., 557 Young, R.F., 1045 Zhou, D., 821
Wiedermann, J.G., 767 Woods, W.G., 335 Yount, G., 95 Ziaja, E.L., 565
Wiens, L.W., 1099 Wright, A.E., 777 Yu, K.H., 291 Zincke, H., 585
Wilcox, J.N., 789 Wu, A., 1225, 1283 Yu, P., 291 Zlotecki, R.A., 325
SUBJECT INDEX
Volume 36, 1996
A cDDP, 135 Early-stage Hodgkin’s disease, 305
Cell kinetics, 497, 1137 Economic issues, 739
Accelerated fractionation, 1137, 1147 Central nervous system tumors, 433 Endothelin, 649
Acoustic neuroma, 275 Cerebral necrosis, 1251 Endovascular brachytherapy, 847
Acoustic neuromas, 141 Cervical cancer, 623 Endovascular irradiation, 933
Acute effects, 1221 Cervix carcinoma, 685 Esophageal cancer, 1091
Acute lymphoblastic leukemia, 19 Chemical dosimetry, 175 Etanidazole, 673
Acute myeloid leukemia, 335 Chemoradiotherapy, 1127 Experimental tumors, 135
Acute skin reactions, 1065 Chemotherapy, 541, 557 External beam radiation, 829
Acute toxicity, 1147 Child, 1251 External beam radiotherapy, 321
Adenocarcinoma, 673 Children, 533 Extravasation, 1177
Adenoid cystic carcinoma, 87 Cisplatin, 105, 281, 999 Ex vivo radiosensitivity, 125
Advanced laryngeal cancers, 1013 c-jun, 355
Adventitia, 789 Clonogenic assay, 821 F
Agarose gel, 175 CNS lymphoma, 429
Aggressive fibromatosis, 325 Colloidal *P, 1117 "°F, 641
AIDS, 429 Combination chemotherapy-radiotherapy, 999 Fast simulated annealing, 711
Air cavity effect, 181 Combined modality treatment, 1077 Flat-panel imager, 661
Aloe vera gel, 345 Complication, 1055 5-Fluorouracil, 641
**! Am, 689 Complications, 1045 ['*F]fluoromisonidazole, 417
9-Aminocamptothecin, 369 Computed tomography, 291, 1091 Fractionated stereotactic radiotherapy, 141
Amorphous silicon array, 661 Computer graphics, 451 Fractionation, 37, 739, 1085
Anaplastic astrocytoma, 1163 Computerized treatment planning, 451
Angioplasty, 777, 829, 847, 913 Computer system design, 451 G
Animal model, 385 Concomitant boost, 1005
Antibiotics, 681 Concurrent, 1127
Apoptosis, 95, 601, 821 Conformal irradiation, 721 G,-arrest, 95
Arterial response, 789 Conservation surgery, 311 G1 Checkpoint-deficient cells, 1099
Arteriovenous malformation, 873 Contralateral, 615 Gamma knife, 1045
Astrocytes, 113 Coronary artery, 829 Germ cell tumors, 557
Astrocytomas, 1251 Coronary artery disease, 881 Glioblastoma multiforme, 95
Ataxia telangiectasia, 355 Cost, 949 Glioma, 105, 393, 403
Attenuation, 205 Cost optimization, 739 Grade, 585
Craniospinal irradiation, 19 Granisetron, 77
Crossfire, 197 Gynecologic, 699
D H
Benign diseases, 891
Biochemical control, 565
Bone marrow transplantation, 3, 67 3D planning, 469 Half-body irradiation (HBI), 49
Bone marrow transplant, 61, 335 3D treatment planning, 159 Head and neck cancer, 469, 999, 1137
Bone metastases, 1085 Delayed radiation necrosis, 1251 Head and neck squamous cell carcinoma,
Boron neutron capture therapy, 241 DFMO, 113 1147
Brachytherapy, 321, 443, 681, 689, 711, 767, Dialysis accesses, 847
Heart function, 811
835, 913, 1039, 1045, 1117, 1201, 1233, Digital imaging, 661 Hemibody irradiation, 37
1239 Diode, 205 High dose rate brachytherapy, 1019
Brain metastases, 443 Diodes, 463 High-dose therapy, 3
Brain neoplasm, 1045 DNA double strand breaks, 125 Historical review, 497
Brain neoplasms, 233, 1251 DNA repair, 125, 361, 369 History of medicine, 481
Brain tissue tolerance, 1055 DNA-Topo I complexes, 361 Hodgkin’s disease, 3, 13, 881
Brain tumors, 241, 557 Dose escalation, 867 Human, 1251
BrdUrd(5-bromo-2-deoxyuridine), 1137 Dose measurement, 463 Hyperdiuresis, 77
Breast cancer, 147 Dose rate, 1201
Hyperthermia, 135, 403, 1169, 1177, 1189
Breast carcinoma, 615 Dose response, 767 Hypothyroidism, 13
Breast-conserving treatment, 615 Dose-volume histograms, 721 Hypoxia, 417
Bromodeoxyuridine, 113 Dosimetry, 197
Hypoxic cells, 377, 1107
BSH, 241 Dosimetry algorithms, 1239
BT,An, 393 Doxorubicin, 1177
BT.Cn, 403 Dupuytren’s disease (contracture), 891
Cc E "251, 689, 1239
Imaging, 417
Carcinoma, 681, 1177 Early breast cancer, 899 Immunohistochemistry, 113
CCAAT box, 355 Early glottic cancer, 1025 Induction chemotherapy, 1005
XXIl
Intensity modulation, 1225 Nausea, 77 Prostate specific antigen, 565
Interstitial, 699 Neointimal hyperplasia, 829 Prostate-specific antigen/bl (blood), 585
Interstitial irradiation, 113 Neoplasm, 1039 Prostatic neoplasms/pa (pathology), 585
Interstitial pneumonitis, 61 Neoplasm staging, 585 Proton, 867
Interstitial radiosurgery, 443 Neutron radiotherapy, 87 Proton spectroscopic imaging, 635
Intracavitary brachytherapy, 1019 New Zealand, 481 PSA, 673
Intracoronary, 913 Nitric oxide, 649 Pulmonary function, 67
Intracoronary irradiation, 767 Nitric oxide donors, 377 Pulsed brachytherapy, 147
Intravascular brachytherapy, 829, 923 2-Nitroimidazole nucleoside, 1107 Pulsed dose rate, 1233
In vivo dosimetry, 189, 205 Nitroprusside, 393, 403 Pyrimidine analogs, 1163
Ir, 351, 689, 1239 NMR spectroscopy, 641
‘Ir endovascular brachytherapy, 835 Nonresectable pancreas, 1117 Q
Irradiation, 135, 635, 841 Nonsmall cell lung cancer, 593
L Nonsmall cell lung carcinoma, 607 Quality assurance, 463
Normal brain, 113
Quality of life, 49, 351
Normal tissues, 497
Labeling index, 113 NPC, 291 R
Lactate, 635 NSCLC, 601
Larynx, 181
Larynx preservation, 1025 oO Radiation, 95, 355, 469, 649, 777, 797, 805,
Late effects, 1221 821, 1225
Late radiation damage, 811 Radiation fields, 175
Late skin reactions, 1065 Occult metastases, 37 Radiation-induced dermatitis, 345
Linac, 1055 Optical density, 175 Radiation injury, 275, 1221
Linear-quadratic, 739 Optimization, 159, 711 Radiation morbidity, 867
Liposarcoma, 311 Oral tongue, 1039 Radiation oncology, 481
Local control, 541 Outcomes, 949
Local neoplasm recurrence, 325 Oxygenation, 623 541, 565, 593, 673, 857, 1005, 1019,
Local tumor control, 247 1039, 1189, 1215
Long-term effects, 899 4 Radioactive '*'I, 83
Long-term rectal bleeding risk, 721 Radiobiological modeling, 739
Low dose rate irradiation, 105 Pp, 933 Radiobiology, 385, 497
Low-grade glioma, 549 p53, 95 Radionuclides, 197
Lung cancer, 1215 Radiosensitization, 377, 999
Pain relief, 1085
Lymphangiogram, 13 Radiosensitizer, 1077
Palliation of cancer pain, 49
Lymph node metastasis, 1091 Radiosensitizers, 1107, 1163
Parallel processing, 159
M Parotid gland, 469 Radiosurgery, 275, 873, 1045, 1055
Radiotherapeutic dose—response, 549
Patterns of Care Study, 731
Macular degeneration, 857, 861, 867 ‘Pd, 689 Radiotherapy, 3, 281, 291, 305, 325, 329,
351, 497, 557, 607, 685, 861, 881, 891,
Magnetic resonance imaging, 623, 1091 Pelvic lymph node irradiation, 573
899, 907, 999, 1025, 1065, 1085, 1091,
Magnetic resonance spectroscopy, 1251 Percutaneous transluminal coronary angio-
1137, 1155
Malignant glioma, 1045 plasty (PTCA), 805
Randomized study, 1077
Medically inoperable, 607 Percutaneous transluminal angioplasty, 835
Randomized trial, 305
Medulloblastoma, 233, 1155 Percutaneous transluminal coronary angio-
Rat, 811
Megavoltage imaging, 661 plasty, 841, 923
Razoxane, 1077
Metachronous, 615 Permanent prostate implant, 711
Metastases, 197 PFGE, 125 RBE, 689
Real time, 159
Methylxanthines, 1099 Pharmacokinetic and metabolic studies, 1107
Recalcification, 1085
Microdosimetry, 689 Phase I, 1117
Reirradiation, 433, 811
Microeconomics, 949 Photon and electron beams, 205
Rejection, 907
Microglia, 113, 649 Photonic radiosurgical system, 443
Renal allograft, 907
Micronucleus, 821 Plasmacytoma, 329
Microspheres, 393 PLDR, 361, 369 Restenosis, 777, 797, 805, 829, 841, 847, 913,
923, 933, 949
Microvascular damage, 899 Porcine model, 767
Rhabdomyosarcoma, 533
Microvascularity, 623 Positive margin(s), 321
RIF-1 tumor, 125
Mitogenic activity, 821 Positron emission tomography, 417 Risk prediction, 1055
Mitosis, 601 Postangioplasty restenosis, 789 RK28, 1107
Molds, 147 Postoperative radiotherapy, 1013, 1147
Morphometric analysis, 113 Predictive assay, 125 Ss
Mucosal dose, 181 Primary breast cancer, 731
Multileaf collimator, 1225 Primitive neuroectodermal tumor, 1155
Myocardial disease, 899 Prognosis, 615, 685 Salivary gland tumors, 87
Myxoid liposarcoma, 311 Prognostic factors, 281, 311, 549, 601, 607, Selectivity, 197
1065 Seminal vesicles/pa (pathology), 585
N Proliferative activity, 685 Sensorineural hearing loss, 281
Prostate, 681, 721 Shared memory, 159
Nasopharyngeal carcinoma, 281, 1005, 1019, Prostate cancer, 565, 573, 585 Sievert integral, 1239
1127 Prostatectomy, 585 Significant prognosticators, 291
XXIll
Silicon diode dosimeter, 189 Template, 699
Simultaneous, 1189 Thermal neutrons, 241
Skin metastases, 147 Thermoluminescent dosimetry, 189
Ultrasound, 1189
SLDR, 361 Thermometry results, 1169
Ultrasound heating, 1 169
Smooth muscle, 821 Thermosensitive liposomes, 1177
Unconventional fractionation, 49
Soft tissue sarcoma, 321, 1077 Three-dimensional treatment planning, 451
Uptime, 1233
Software engineering, 451 Thyroid carcinoma, 83
User interfaces, 451
Spinal cord, 649 Thyroid gland, 1221
Utility, 949
Squamous cell carcinoma, 351 Thyroiditis, 1221
Stage, 585 Thyroid stimulating hormone, 1221 Vv
Stents, 797 Thyrotoxicosis, 1221
Stereotactic, 1055 TLD extrapolation, 181
Vascular permeability, 649
Stereotactic radiosurgery, 385 T of the TNM staging classification, 549
Vestibular schwannoma, 275
Stereotactic surgery, 873 Tongue cancer, 1201
Vomiting, 77
Stereotactic techniques, 443 Tongue neoplasms, 351
VX2 tumor, 1107
Subfoveal choroidal neovascularization, 867 Topoisomerase I, 361, 369
Subfoveal neovascularization, 861 Topotecan, 1215 Ww
Sufficient extended field treatment dose, 305 Total-body irradiation, 61
Superoxide dismutase, 649 Total body irradiation, 67, 77, 463
Surgery, 891, 1025 Total marrow irradiation, 189 Wilms’ tumor, 541
Survival, 1045 Transducer, 1169 Window chamber, 1177
Survival analysis, 329 Transperineal, 699
xX
Syed-Neblett, 699 Transplantation, 907
Treatment outcome, 601
T Treatment planning, 711, 731 Xerostomia, 469
Treatment verification, 463
Y
Tumor perfusion, 623
Technetium 99-m sestamibi perfusion scintig- Tumors, 497, 635
raphy, 899 Tumor volume, 247 Yb, 1239